
Thomas Barnet
Journalist

Major speculative move on Soitec
Soitec is climbing higher and higher. The stock is up approximately 15% in intraday trading, despite benign sector news and the absence of specific official information. With no response from the professionals covering the stock, it was necessary to dig elsewhere.
March 11, 2026 at 08:28 pm IST
Oil remains close to $90 per barrel, despite WSJ revelations
The International Energy Agency is considering an unprecedented move: releasing more oil than the 182 million barrels unlocked in 2022 after Russia's invasion of Ukraine, The Wall Street Journal reported overnight.
March 11, 2026 at 03:01 pm IST
Oil Holds Near $90, Despite WSJ Revelations
The International Energy Agency is weighing an unprecedented move: releasing more oil than the 182 million barrels unlocked in 2022 after Russia's invasion of Ukraine, The Wall Street Journal reported overnight.
March 11, 2026 at 01:55 pm IST
Lindt, Eurofins Cerep, Lotus Bakeries... European stocks with eye-watering share prices
The release of Lindt's results, poorly received, no less, is an opportunity to take a look at Western European listed stocks whose prices are extremely high. The Swiss chocolatier's main share trades around CHF 115,000, or roughly 5 years of the median French net salary.
March 10, 2026 at 02:43 pm IST
Equinor Announces Two Oil and Gas Discoveries in the North Sea
Equinor has discovered oil in the Troll area and gas with condensate in the Sleipner area, two finds deemed commercially viable and located near already well-developed infrastructure for exports to Europe.
March 10, 2026 at 01:21 pm IST
Vaziva launches €8 million convertible bond issue
The company specializing in employee benefit cards is set to raise funds through a private placement of bonds convertible into new shares (OCA) for a maximum amount of €8 million. The operation is intended to support the company's growth strategy and finance its European rollout.
March 09, 2026 at 10:56 pm IST
FDA grants Orphan Drug Designation to Genfit's NTZ for ACLF
The FDA has granted Orphan Drug Designation (ODD) to nitazoxanide (NTZ), developed by Genfit for the treatment of acute-on-chronic liver failure (ACLF), a severe condition with no currently approved therapies.
March 09, 2026 at 10:44 pm IST
Why TotalEnergies is failing to capitalize on surging oil prices
Despite oil prices jumping by over 50% in just ten days, TotalEnergies shares remain roughly where they were at the end of February. This muted reaction is largely due to two primary factors.
March 09, 2026 at 03:41 pm IST
Why TotalEnergies is failing to capitalize on surging oil prices
Despite oil prices jumping more than 50% in ten days, TotalEnergies shares remain roughly where they were at the end of February. This muted reaction can be attributed to two primary factors.
March 09, 2026 at 03:07 pm IST
Discover our authors
Chief Editor
Journalist
Analyst
Analyst
Analyst
- Stock Market
- Our authors
- Thomas Barnet



























